Class IIITerminatedD-0550-2018
Drug recall · March 7, 2018
Cystaran recall
Why: Subpotent Drug: Out of specification for an active ingredient cysteamine hydrochloride.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Cystaran (cysteamine ophthalmic solution) 0.44%, 15 mL bottle, Rx only, Manufactured by Hi-Tech Pharmacal Co. Inc., Amityville, NY 11701 for Leadiant Biosciences, Inc., Gaithersburg, MD 20878, NDC 54482-020-01
- Lots / codes
Lot #: 356075, Exp 2/28/18
- Quantity
- 1,705 bottles
- Company
- Leadiant Biosciences, Inc, Gaithersburg, MD
- Distribution
- Product was distributed to one specialty pharmacy distributor in the US Walgreens Specialty Pharmacy 16287, 130 Enterprise Drive Pittsburgh, PA 15275 Foreign Account: Italy
- Initiated
- February 14, 2018 · Voluntary: Firm initiated
- Classified
- February 28, 2018
- Reported
- March 7, 2018
- Ended
- November 29, 2018
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.